FierceBiotech Dec 15, 2025 J&J-backed Link launches with $60M, plan to create next-gen CAR-T therapies
FierceBiotech Dec 15, 2025 Kyverna gains clear view to first CAR-T approval for autoimmune disease after 'truly remarkable' SPS readout
FierceBiotech Dec 15, 2025 Beyond the ADC Hype: Innovation is accelerating through bispecifics and dual payload strategies
FierceBiotech Dec 13, 2025 GAO probe finds understaffed FDA putting some medical device recall work on the 'back burner'
FierceBiotech Dec 12, 2025 Obesity biotech Zealand seeks partners to ‘take therapies directly to the brain’
FierceBiotech Dec 12, 2025 Cycle seizes struggling Applied Tx, picking up rare disease biotech for pennies per share
FierceBiotech Dec 12, 2025 2026 outlook: Biotech poised to outperform bear markets of ’21-24, analyst says
FierceBiotech Dec 12, 2025 Leading the Way in Biotech Solutions Across Japan and Asia Pacific (JAPAC)
FierceBiotech Dec 11, 2025 Amgen obesity marketing leader Chris Boulton takes reins at metabolic biotech Prolynx